What systematic and institutional changes do we see ahead of us? What should we have a sense of urgency about? How can, and should, we change our systems in the future? How can learning from changes due to Corona help us further?

 

Watch the background videos/interviews via the following links:

 

Anne Borg, Rector at Norwegian University of Technology and Science

 

Arne Flåøyen, Director in Nordforsk

 

Bjørn Taale Sandberg, Senior Vice President & Head of Telenor Research

 

Dag Rune Olsen, Vice-Cancellor at University Bergen 

 

Sven Stafström, Director General in the Swedish Research Council

What should we do next?

Download the presentation (pdf) by Gunnar Bovim

Download Opening Presentation From The Third Webinar What Should We Do Next

Conclusion from Webinar 2

A brief presentation of the main conclusions from the groups at webinar 2

Download Conclusions From Webinar 2

Background material

Report: To achieve its goal, we believe that the EIC should become a hands-on innovation agency. In our view, to create the EIC way in the European landscape for supporting breakthrough innovation, the main components are centred on the creation of challenge- and thematic-driven programmes, active portfolio management of funded projects, transition activities that bring new solutions to the market and EIC PMs who bind all of this together into complementary practices.

 

The EU is drawing lessons from the COVID-19 crisis, with new policy initiatives brought forward by the European Commission on better preparedness for future health threats. To support and inform that process, we as science and ethics advisors have examined evidence on the responses to the COVID-19 and, in part, to previous pandemics - which has revealed important lessons learned and to be learned. On that basis, we have formulated a range of recommendations.

 

The Common Statement of the Group Chief Scientific Advisors (GCSA) and European Group on Ethics in Science and New Technologies (EGE) on policy advice during the COVID-19 crisis.

 

A summary of a scientific opinion by the Group of Chief Scientific Advisors, an Independent expert group providing high-quality and timely scientific advice to the European Commission, to inform European Union policies and legislation, and informed by SAPEA evidence review reports. 

 

Heathcare innovation: building on gains made through the crises 

McKinsey article: Leaders should consider the lessons and achievements of the COVID-19 crisis in forging new innovation aspirations - and the mechanisms needed to execute them.

 

Briefing: The impact of the Covid-19 crises on university funding in Europe

The coronavirus pandemic that has swept over Europe and the rest of the world has posed unprecedented challenges for all sectors of the economy, and higher education is no exception. The European University Association has been closely following university funding trends in Europe since 2008. In this briefing from May 2020, several projections are made about the immediate and longer effects of the coronavirus pandemic on European universities and possible ways to mitigate them.

 

McKinsey article: The age of the insular R&D organization is over. To serve as a company’s innovation engine, R&D strategy needs to be equipped for today’s fast-moving world.